189 related articles for article (PubMed ID: 26546192)
21. Color Doppler sonography in Graves' disease: value in assessing activity of disease and predicting outcome.
Castagnone D; Rivolta R; Rescalli S; Baldini MI; Tozzi R; Cantalamessa L
AJR Am J Roentgenol; 1996 Jan; 166(1):203-7. PubMed ID: 8571877
[TBL] [Abstract][Full Text] [Related]
22. Prediction of relapse after antithyroid drug therapy of Graves' disease: value of color Doppler sonography.
Saleh A; Cohnen M; Fürst G; Mödder U; Feldkamp J
Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):510-3. PubMed ID: 15505758
[TBL] [Abstract][Full Text] [Related]
23. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
Ide A; Amino N; Kang S; Yoshioka W; Kudo T; Nishihara E; Ito M; Nakamura H; Miyauchi A
Thyroid; 2014 Jun; 24(6):1027-31. PubMed ID: 24400892
[TBL] [Abstract][Full Text] [Related]
25. Is rapid preparation for thyroidectomy in severe Graves' disease beneficial? The relationship between clinical and immunohistochemical aspects.
Hassan I; Danila R; Aljabri H; Hoffmann S; Wunderlich A; Karakas E; Zielke A
Endocrine; 2008 Apr; 33(2):189-95. PubMed ID: 18493879
[TBL] [Abstract][Full Text] [Related]
26. Does Surgery Without Lugol's Solution Pretreatment for Graves' Disease Increase Surgical Morbidity?
Mercier F; Bonal M; Fanget F; Maillard L; Laplace N; Peix JL; Lifante JC
World J Surg; 2018 Jul; 42(7):2123-2126. PubMed ID: 29302725
[TBL] [Abstract][Full Text] [Related]
27. Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves' disease and diffuse toxic goiter.
Saleh A; Cohnen M; Fürst G; Godehardt E; Mödder U; Feldkamp J
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):32-6. PubMed ID: 11835123
[TBL] [Abstract][Full Text] [Related]
28. [Mean arterial blood flow depends on the intensity of thyrotoxicosis in patients with Graves' disease].
Czarkowski M; Hilgertner L; Powałowski T; Radomski D
Pol Merkur Lekarski; 2005 Jun; 18(108):667-70. PubMed ID: 16124380
[TBL] [Abstract][Full Text] [Related]
29. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.
Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J
J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381
[TBL] [Abstract][Full Text] [Related]
30. [Effect of preoperative administration of Lugol's solution on thyroid blood flow in hyperthyroidism].
Rodier JF; Janser JC; Petit H; Schneegans O; Ott G; Kaissling A; Grob JC; Velten M
Ann Chir; 1998; 52(3):229-33. PubMed ID: 9752450
[TBL] [Abstract][Full Text] [Related]
31. Role of thyroid Doppler in differential diagnosis of thyrotoxicosis.
Hari Kumar KV; Pasupuleti V; Jayaraman M; Abhyuday V; Rayudu B R; Modi KD
Endocr Pract; 2009; 15(1):6-9. PubMed ID: 19211390
[TBL] [Abstract][Full Text] [Related]
32. Scintigraphic findings of the thyroid in euthyroid ophthalmic Graves' disease.
Kasagi K; Hidaka A; Misaki T; Miyamoto S; Takeuchi R; Sakahara H; Sasayama S; Iida Y; Konishi J
J Nucl Med; 1994 May; 35(5):811-7. PubMed ID: 8176463
[TBL] [Abstract][Full Text] [Related]
33. Thyroid blood flow as a useful predictor of relapse of Graves' disease after normal delivery in patients with Graves' disease.
Nagasaki T; Inaba M; Fujiwara-Ueda M; Nishio J; Kumeda Y; Hiura Y; Tahara H; Ishimura E; Ishiko O; Nishizawa Y
Biomed Pharmacother; 2010 Feb; 64(2):113-7. PubMed ID: 20006462
[TBL] [Abstract][Full Text] [Related]
34. [The characteristics of two-dimensional and color Doppler ultrasonography in Graves' disease].
Li J; Zhang J; Bai Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):170-4. PubMed ID: 7805159
[TBL] [Abstract][Full Text] [Related]
35. Mean peak systolic velocity of the superior thyroid artery is correlated with radioactive iodine uptake in untreated thyrotoxicosis.
Chen L; Zhao X; Liu H; Wang Y; Li L; Lu B; Li Y; Hu R
J Int Med Res; 2012; 40(2):640-7. PubMed ID: 22613425
[TBL] [Abstract][Full Text] [Related]
36. Lugol's iodine: its effect on thyroid blood flow in patients with thyrotoxicosis.
Marigold JH; Morgan AK; Earle DJ; Young AE; Croft DN
Br J Surg; 1985 Jan; 72(1):45-7. PubMed ID: 3967130
[TBL] [Abstract][Full Text] [Related]
37. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
38. Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.
Rubio GA; Koru-Sengul T; Vaghaiwalla TM; Parikh PP; Farra JC; Lew JI
Thyroid; 2017 Jun; 27(6):825-831. PubMed ID: 28457178
[TBL] [Abstract][Full Text] [Related]
39. Thyroid Doppler ultrasonography and resistive index in the evaluation of the need for ablative or antithyroid drug therapy in Graves' hyperthyroidism.
Wang CY; Chang TC
J Formos Med Assoc; 2001 Nov; 100(11):753-7. PubMed ID: 11802534
[TBL] [Abstract][Full Text] [Related]
40. Measurement of thyroid blood flow area is useful for diagnosing the cause of thyrotoxicosis.
Kurita S; Sakurai M; Kita Y; Ota T; Ando H; Kaneko S; Takamura T
Thyroid; 2005 Nov; 15(11):1249-52. PubMed ID: 16356088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
